Promisia Healthcare HY26 Interim Results

Promisia Healthcare Limited (Promisia) (NZX: PHL) has announced its unaudited results for the six months ended 30 September 2025 (HY26). The first half of FY26 marks a significant milestone for Promisia. After a year laying new foundations, the company is now demonstrating disciplined execution and meaningful operational momentum across every part of its business. • Underlying EBITDAF up 31% to $2.5 million with operating revenue rising 47% to $19.2 million in HY26 • Group care occupancy improved from 87% to 90% since March 2025; Aldwins House reaching record occupancy above 90% • New Chief Operating Officer delivers rapid results through comprehensive facility health checks, operational improvements and unified systems implementation • Balance sheet strengthened through disciplined capital allocation with non-core Aldwins properties sold and free cash flow applied to Golden View ownership advancement • Pro-forma LVR improving to approximately 40.7% • Positioned for sustainable growth with early-stage acquisition negotiations underway supported by improving earnings and reduced leverage • Full-year earnings guidance reaffirmed: underlying EBITDAF of at least $6.1 million — representing more than 45% year-on-year growth For further information on Promisia's six month performance, please read the Interim Report for the six months ended 30 September 2025.